GL1X · GenesisL1 explorer

MolNFT v1 · #78547 · protein

First crystal structure of an endo-inulinase, from aspergillus ficuum: structural analysis and comparison with other GH32 enzymes.

3SC7: “First crystal structure of an endo-inulinase, from aspergillus ficuum: structural analysis and comparison…”. X-ray diffraction, 3 ligands (MAN, NAG, BMA), 6 pockets (best druggability 0.57). MolNFT v1 #78547 on GenesisL1: 3D…

PDB
3SC7
Type
protein
Length
493 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Inulinase
EC
3.2.1.7
UniProt
O94220
Ligands
MAN, NAG, BMA
Pockets
6 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XInulinase (EC 3.2.1.7)protein4933% helix, 48% strandO94220

Ligands and binding sites

  • MAN · alpha-D-mannopyranose · sugar · 3 copies · chains X
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains X
  • BMA · beta-D-mannopyranose · sugar
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13360.570.7634empty
22150.490.7536empty
31270.490.8031empty
4520.350.7912empty
5500.350.7917empty

Modifications

Observed in the structure: 1 glycan (N-glycosylation).

Compared structures

  • 3SC7 · First crystal structure of an endo-inulinase, from Aspergillus ficuum: structural… · the same entry in another collection · chain X against X, TM-score 1.00
  • O94220 · AlphaFold monomer V2.0 prediction for extracellular endo-inulinase INU2 (O94220) · a predicted model of the same protein · chain X against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.